Abstract
BackgroundPeroxisome proliferator-activated receptors (PPARs) are nuclear receptors known to modulate fibrosis. The pan-PPAR agonist IVA337 recently demonstrated efficacy in prevention and treatment of experimental skin fibrosis (1).ObjectivesOur objective was to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have